Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.

Triamcinolone acetonide is more effective than cryotherapy for hair regrowth in alopecia areata but has different side effects.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Start with 2.5 mg/mL triamcinolone acetonide for scalp alopecia areata and increase if needed.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Intralesional triamcinolone acetonide effectively treats acne keloidalis nuchae with minimal side effects.

Intralesional triamcinolone is more effective than topical betamethasone for treating localized alopecia areata.

Baricitinib is effective as a treatment for severe hair loss.

The luliconazole shampoo effectively reduces symptoms of seborrheic dermatitis and is well-tolerated.

SSRIs can cause hair loss, especially sertraline, with higher risk in women.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Microneedling with Triamcinolone acetonide is an effective, less invasive, and safe alternative to direct injections for treating alopecia areata.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

A 3-year-old boy's scalp infection was treated with ketoconazole.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Triamcinolone hexacetonide is effective but has side effects, while PRP and minoxidil are safer alternatives for treating alopecia areata.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.